A biotech management recruiter commented:<p><pre><code> MA will pull away with the lead soon from Bay Area
based on cost of living. I have senior management
members tell me daily that they'll move anywhere
BUT Bay Area. You'll pay $3.2m for 3/4 BR in Palo
Alto. South Bay and North Bay aren't too much better.</code></pre>
Oklahoma City has a small but strong Biotech and medical device scene ($6.7B Revenue, $2.2B salaries for a workforce of 51,000). Even then most companies in OKC raise money in SF & Boston and either have an office there or move back and forth. Which is pointed out in the section on satellite offices. The satellite office trend I don't see stopping given how cheap flights are and how fast communications have become between coasts.
> These data are striking.<p>The use of 'data' to mean 'plural of datum' continues to fall out of favor in modern usage. Encountering it in a Saturday-morning browse was a note of angelic harmony to start the day.
Wow this article is pretty condescending towards the biotech scene in Europe...<p>I'm going to go out on a limb here and say, maybe there are fewer biotech startups in Europe because profiting off of people's illnesses is generally frowned upon?<p>My guess is progress in that area falls more into the realm of government grants, with maybe the exception of classical pharmaceuticals (there are plenty of old companies like Bayer).<p>Biotech is not my field so I'd be interested in hearing other people's opinions.